CD8A and neoplasm: Upon treatment with ExoBlock, T-cell-mediated tumor suppression was significantly enhanced along with an increase in the number and function of CD4 and CD8 T-cells, which are involved in reducing tumor metastasis, thus providing promising antitumor therapy (221).